Every few years, aging researchers add another item to the growing list of “hallmarks of aging,” the cellular processes that seem to break down as we get older. A new editorial in Aging Medicine takes the opposite approach: it describes the hallmarks the authors have studied for 13 years and argues NAD+ is a common thread.[1]
The researchers, a team spanning Norway, Denmark, China, and the US, focus on three specific breakdowns: genomic instability (DNA damage piling up faster than your cells can fix it), defective macroautophagy (the cellular “cleanup crew” losing its edge), and mitochondrial dysfunction (your cells’ power plants running less efficiently). Individually, each has been linked to age-related disease. Together, the authors argue, they help explain conditions ranging from rare premature-aging disorders like Werner syndrome to everyday problems like dementia and sarcopenia, the age-related loss of muscle mass and strength.
The thread connecting all three
Here’s the part worth paying attention to: across all three breakdowns, the researchers keep running into the same shortage: NAD+ (nicotinamide adenine dinucleotide), a molecule every cell needs to produce energy and repair damage. The editorial describes reduced NAD+ as a commonality between many of these hallmarks, and suggests that raising NAD+ availability may stimulate “mitophagy” (the process that clears out damaged mitochondria), a possible direction for future therapies aimed at multiple age-related diseases at once.
It’s worth being precise about what this is and isn’t. This is an editorial synthesizing existing lab and early clinical evidence, not a new clinical trial, and the authors are explicit that future work needs to map how these hallmarks interact before any of this becomes a standard treatment. If you’ve seen NAD+ boosters marketed as an anti-aging fix, this research explains why the molecule is interesting, but it isn’t a green light to self-supplement your way to younger cells. Talk to your doctor before starting any new supplement, especially if you’re managing an existing condition.
One more thing to know: the first author and two co-authors declare commercial ties to NAD+ precursor companies (ChromaDex, Niagen Bioscience) and a longevity fund (VitaDAO).[1]
The editorial does not discuss exercise or protein, so it offers no everyday steps. If you are concerned about muscle mass or strength as you age, a clinician can advise on what is appropriate for you.
References
- Fang EF, Nilsen H, Scheibye-Knudsen M, Bohr VA, Kang L. “Insights Into the Mechanisms of Biological Aging That Guide Translational and Clinical Research.” Aging Medicine, 2026;9(4):370-373. DOI: 10.1002/agm2.70107. Finding used: the editorial identifies genomic instability, defective macroautophagy, and mitochondrial dysfunction as three key hallmarks of aging, with declining NAD+ as a common link, and describes stimulating mitophagy by improving NAD+ availability as a possible therapeutic direction requiring further study. ↑︎
Kurt Greiner
Kurt is a digital strategist and IT professional blending emerging technology with practical application to help businesses and individuals streamline their digital presence. His current work focuses on the intersection of intentional living and technological resilience, exploring how individuals can leverage modern tools to navigate the second half of life with purpose.
Leave a Reply